Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways ...

Trump celebrated when the Supreme Court limited nationwide blocks on his policies, but judges are finding other ways to ...

British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March ...

The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr.

A Cambridge-based company developing gene therapies for rare diseases is laying off more than a third of its workforce.

The layoffs followed a March announcement by Health Secretary Robert F. Kennedy Jr., who called for a major department overhaul.

An estimated 53 drugs would not enter the market in the next 30 years if the NIH is hit with a permanent 10% budget cut and the FDA experiences a nine-month drug review delay due to staffing cuts, the ...

Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.

Sarepta Therapeutics announced a layoff of 493 employees, including 80 in Franklin County, amid restructuring efforts and ...

Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.

The mass firing of State Department employees could significantly impact the Trump administration’s ability to address the ...